Bergstrom Donald A (CIK 1709772) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-08). Recent activity: Sell RLAY (8,660 shares), Buy RLAY (93,456 shares), Sell RLAY (93,456 shares), Sell RLAY (1,490 shares), Sell RLAY (18,895 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 8,660 | $162,029 |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Buy | 93,456 | $385,039 |
| 2026-06-24 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 93,456 | $1.6M |
| 2026-04-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 1,490 | $22,037 |
| 2026-01-29 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 18,895 | $143,980 |
| 2026-01-29 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 2,686 | $22,697 |
| 2025-10-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 30,897 | $225,239 |
| 2025-07-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 4,069 | $15,218 |
| 2025-07-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 26,701 | $98,260 |
| 2025-04-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 4,090 | $12,965 |
| 2025-04-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 27,472 | $82,416 |
| 2025-03-31 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 986 | $2,800 |
| 2025-01-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 3,220 | $14,909 |
| 2025-01-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Buy | 176,400 | $0 |
| 2025-01-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 46,407 | $211,152 |
| 2025-01-30 | Relay Therapeutics, Inc. (RLAY) | President, R&D | Sell | 30,823 | $136,238 |
Source: SEC Form 4 filings · as of 2026-07-08